22 results on '"LOPES, HENO F."'
Search Results
2. Visceral adiposity syndrome and cardiometabolism
- Author
-
Lopes Heno F. and Egan Brent M.
- Subjects
visceral adiposity ,sympathetic nervous system ,hypothalamic-pituitary-adrenal axis ,cardiometabolism ,Medicine - Abstract
The distribution of fat in the human body is related to hemodynamic and metabolic homeostasis. Brown fat is inversely related to body mass index and is associated with a lower probability of developing diabetes. Beige adipose tissue shares some functional characteristics with brown adipose tissue. White adipose tissue constitutes the majority of the fatty tissue and is mainly distributed in the subcutaneous and abdominal cavity. Intra-abdominal white fat has gained prominence in recent years for its association with cardiovascular risk factors and higher cardiovascular mortality. This review article discusses the human adaptation in the environment, a sympathovagal and hypothalamic-pituitary-adrenal imbalance as a possible cause of increased visceral adiposity and its consequences on cardiometabolism.
- Published
- 2021
- Full Text
- View/download PDF
3. The impact of metabolic syndrome on metabolic, pro-inflammatory and prothrombotic markers according to the presence of high blood pressure criterion
- Author
-
Gil, Juliana S., Drager, Luciano F., Guerra-Riccio, Grazia M., Mostarda, Cristiano, Irigoyen, Maria C., Costa-Hong, Valeria, Bortolotto, Luiz A., Egan, Brent M., and Lopes, Heno F.
- Published
- 2013
- Full Text
- View/download PDF
4. Obstructive Sleep Apnea Is Highly Prevalent and Correlates With Impaired Glycemic Control in Consecutive Patients With the Metabolic Syndrome
- Author
-
Drager, Luciano F., Queiroz, Eduardo L., Lopes, Heno F., Genta, Pedro R., Krieger, Eduardo M., and Lorenzi-Filho, Geraldo
- Published
- 2009
- Full Text
- View/download PDF
5. Acute Hyperlipidemia Increases Oxidative Stress More in African Americans Than in White Americans
- Author
-
Lopes, Heno F, Morrow, Jason D, Stoijiljkovic, Milos P, Goodfriend, Theodore L, and Egan, Brent M
- Published
- 2003
- Full Text
- View/download PDF
6. The Cholinergic Drug Galantamine Alleviates Oxidative Stress Alongside Anti-inflammatory and Cardio-Metabolic Effects in Subjects With the Metabolic Syndrome in a Randomized Trial.
- Author
-
Sangaleti, Carine Teles, Katayama, Keyla Yukari, De Angelis, Kátia, Lemos de Moraes, Tércio, Araújo, Amanda Aparecida, Lopes, Heno F., Camacho, Cleber, Bortolotto, Luiz Aparecido, Michelini, Lisete Compagno, Irigoyen, Maria Cláudia, Olofsson, Peder S., Barnaby, Douglas P., Tracey, Kevin J., Pavlov, Valentin A., and Consolim Colombo, Fernanda Marciano
- Subjects
PARASYMPATHOMIMETIC agents ,GALANTHAMINE ,OXIDATIVE stress ,METABOLIC syndrome ,HEART beat - Abstract
Background: The metabolic syndrome (MetS) is an obesity-associated disorder of pandemic proportions and limited treatment options. Oxidative stress, low-grade inflammation and altered neural autonomic regulation, are important components and drivers of pathogenesis. Galantamine, an acetylcholinesterase inhibitor and a cholinergic drug that is clinically-approved (for Alzheimer's disease) has been implicated in neural cholinergic regulation of inflammation in several conditions characterized with immune and metabolic derangements. Here we examined the effects of galantamine on oxidative stress in parallel with inflammatory and cardio-metabolic parameters in subjects with MetS. Trial Design and Methods: The effects of galantamine treatment, 8 mg daily for 4 weeks or placebo, followed by 16 mg daily for 8 weeks or placebo were studied in randomly assigned subjects with MetS (n = 22 per group) of both genders. Oxidative stress, including superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase activities, lipid and protein peroxidation, and nitrite levels were analyzed before and at the end of the treatment. In addition, plasma cytokine and adipokine levels, insulin resistance (HOMA-IR) and other relevant cardio-metabolic indices were analyzed. Autonomic regulation was also examined by heart rate variability (HRV) before treatment, and at every 4 weeks of treatment. Results: Galantamine treatment significantly increased antioxidant enzyme activities, including SOD [+1.65 USOD/mg protein, [95% CI 0.39–2.92], P = 0.004] and CAT [+0.93 nmol/mg, [95% CI 0.34–1.51], P = 0.01], decreased lipid peroxidation [thiobarbituric acid reactive substances [log scale 0.72 pmol/mg, [95% CI 0.46–1.07], P = 0.05], and systemic nitrite levels [log scale 0.83 μmol/mg protein, [95% CI 0.57–1.20], P = 0.04] compared with placebo. In addition, galantamine significantly alleviated the inflammatory state and insulin resistance, and decreased the low frequency/high frequency ratio of HRV, following 8 and 12 weeks of drug treatment. Conclusion: Low-dose galantamine alleviates oxidative stress, alongside beneficial anti-inflammatory, and metabolic effects, and modulates neural autonomic regulation in subjects with MetS. These findings are of considerable interest for further studies with the cholinergic drug galantamine to ameliorate MetS. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
7. The pressor response to acute hyperlipidemia is enhanced in lean normotensive offspring of hypertensive parents
- Author
-
Lopes, Heno F, Stojiljkovic, Milos P, Zhang, Da, Goodfriend, Theodore L, and Egan, Brent M
- Published
- 2001
- Full Text
- View/download PDF
8. Hemodynamic effects of lipids in humans
- Author
-
STOJILJKOVIC, MILOS P., ZHANG, DA, LOPES, HENO F., LEE, CHRISTINE G., GOODFRIEND, THEODORE L., and EGAN, BRENT M.
- Subjects
Lipids -- Abnormalities ,Hypertension -- Causes of ,Hypertension -- Genetic aspects ,Biological sciences - Abstract
Evidence suggests lipid abnormalities may contribute to elevated blood pressure, increased vascular resistance, and reduced arterial compliance among insulin-resistant subjects. In a study of 11 normal volunteers undergoing 4-h-long infusions of Intralipid and heparin to raise plasma nonesterified fatty acids (NEFAs), we observed increases of blood pressure. In contrast, blood pressure did not change in these same volunteers during a 4-h infusion of saline and heparin. To better characterize the hemodynamic responses to Intralipid and heparin, another group of 21 individuals, including both lean and obese volunteers, was studied after 3 wk on a controlled diet with 180 mmol sodium/day. Two and four hours after starting the infusions, plasma NEFAs increased by 134 and 111% in those receiving Intralipid and heparin, P [is less than] 0.01, whereas plasma NEFAs did not change in the first group of normal volunteers who received saline and heparin. The hemodynamic changes in lean and obese subjects in the second study were similar, and the results were combined. The infusion of Intralipid and heparin induced a significant increase in systolic (13.5 [+ or -] 2.1 mmHg) and diastolic (8.0 [+ or -] 1.5 mmHg) blood pressure as well as heart rate (9.4 [+ or -] 1.4 beats/min). Small and large artery compliance decreased, and systemic vascular resistance rose. These data raise the possibility that lipid abnormalities associated with insulin resistance contribute to the elevated blood pressure and heart rate as well as the reduced vascular compliance observed in subjects with the cardiovascular risk factor cluster. hypertension; nonesterified fatty acids; blood pressure
- Published
- 2001
9. Does Obstructive Sleep Apnea Influence Blood Pressure and Arterial Stiffness in Response to Antihypertensive Treatment?
- Author
-
Fatureto-Borges, Fernanda, Jenner, Raimundo, Costa-Hong, Valéria, Lopes, Heno F., Teixeira, Sandra H., Marum, Elias, Giorgi, Dante A.m., Consolim-Colombo, Fernanda M., Bortolotto, Luiz A., Lorenzi-Filho, Geraldo, Krieger, Eduardo M., and Drager, Luciano F.
- Abstract
Untreated obstructive sleep apnea (OSA) is common in patients with hypertension and may impair blood pressure (BP) and target-organ damage responses to antihypertensive therapy. In this study, we recruited hypertensive patients who underwent treatment with a 30-day regimen of hydrochlorothiazide 25 mg plus enalapril (20 mg BID) or losartan (50 mg BID) and were assessed with a baseline clinical evaluation, polysomnography, 24-hour ambulatory BP monitoring, and carotid-femoral pulse wave velocity. All the examinations except for polysomnography were repeated at 6 and 18 months of follow-up. We studied 94 hypertensive patients (mean age, 55±9 years). The frequency of OSA was 55%. Compared with baseline, we did not observe significant differences between groups in 24-hour BP, daytime systolic and diastolic BPs, or night-time systolic BP at 6 and 18 months. The BP control rate at 24 hours (<130/80 mm Hg) was similar between the groups (baseline, 42.3% versus 45.2%; 6 months, 46.9% versus 57.5%; 18 months, 66.7% versus 61.5%). However, patients with OSA had higher night-time diastolic BP decrease than did the non-OSA group (6 months, -4.9±11.8 versus -0.3±10.3 mm Hg; 18 months, -6.7±11.1 versus -1.2±10.6 mm Hg; P=0.027). There were no differences in the number and class of antihypertensive medications prescribed during follow-up. In terms of arterial stiffness, patients with OSA had higher pulse wave velocity than did patients without OSA at baseline (10.3±1.9 versus 9.2±1.7 m/s; P=0.024), but both groups had similar decreases in pulse wave velocity during follow-up. In conclusion, with combined antihypertensive treatment aimed at controlling BP, hypertensive patients with OSA had similar 24-hour BP and arterial stiffness to those without OSA. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
10. Predictors of Obstructive Sleep Apnea in Consecutive Patients with Metabolic Syndrome.
- Author
-
Pedrosa, Rodrigo P., Maki-Nunes, Cristiane, Midlej-Brito, Thiago, Lopes, Heno F., Freitas, Lunara S., Trombetta, Ivani C., Toschi-Dias, Edgar, Alves, Maria Janieire N.N., Fraga, Raffael F., Rondon, Maria U., Negrão, Carlos E., Bortolotto, Luiz A., Lorenzi-Filho, Geraldo, and Drager, Luciano F.
- Abstract
Background: Recent evidence suggests that obstructive sleep apnea (OSA) is common in patients with metabolic syndrome (MetS) and may contribute to metabolic deregulation, inflammation, and atherosclerosis in these patients. In clinical practice, however, OSA is frequently underdiagnosed. We sought to investigate the clinical predictors of OSA in patients with MetS. Methods: We studied consecutive patients newly diagnosed with MetS (Adult Treatment Panel-III). All participants underwent clinical evaluation, standard polysomnography, and laboratory measurements. We performed a logistic regression model, including the following variables: gender, age >50 years, neck and waist circumferences, hypertension, diabetes, body mass index (BMI) >30 kg/m
2 , high risk for OSA by Berlin questionnaire, presence of excessive daytime somnolence (Epworth Sleepiness Scale), abnormal serum glucose, triglycerides, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol. Results: We studied 197 patients (60% men; age: 49 ± 10 years; BMI: 32.9 ± 5.1 kg/m2 ). OSA (defined by an apnea-hypopnea index ≥15 events per hour) was diagnosed in 117 patients [59%; 95% confidence interval (CI): 52-66]. In multivariate analysis, male gender [odds ratio (OR): 3.28; 95% CI: 1.68-6.41; P < 0.01], abnormal glucose levels (OR: 3.01; 95% CI: 1.50-6.03; P < 0.01), excessive daytime sleepiness (OR: 2.38; 95% CI: 1.13-5.04; P = 0.02), and high risk for OSA by Berlin questionnaire (OR: 4.33; 95% CI: 2.06-9.11; P < 0.001) were independently associated with OSA. Conclusions: Simple clinical and metabolic characteristics may help to improve the underdiagnosis of OSA in patients with MetS. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
11. Association of obstructive sleep apnea with arterial stiffness and nondipping blood pressure in patients with hypertension.
- Author
-
Jenner, Raimundo, Fatureto ‐ Borges, Fernanda, Costa ‐ Hong, Valéria, Lopes, Heno F., Teixeira, Sandra H., Marum, Elias, Giorgi, Dante A. M., Consolim ‐ Colombo, Fernanda M., Bortolotto, Luiz A., Lorenzi ‐ Filho, Geraldo, Krieger, Eduardo M., Drager, Luciano F., Fatureto-Borges, Fernanda, Costa-Hong, Valéria, Consolim-Colombo, Fernanda M, and Lorenzi-Filho, Geraldo
- Abstract
Whether sex influences the association of obstructive sleep apnea (OSA) with markers of cardiovascular risk in patients with hypertension is unknown. In this study, 95 hypertensive participants underwent carotid-femoral pulse wave velocity, 24-hour ambulatory blood pressure monitoring, echocardiogram, and polysomnography after a 30-day standardized treatment with hydrochlorothiazide plus enalapril or losartan. OSA was present in 52 patients. Compared with non-OSA patients, pulse wave velocity values were higher in the OSA group (men: 11.1±2.2 vs 12.7±2.4 m/s, P=.04; women: 11.8±2.4 vs 13.2±2.2 m/s, P=.03). The proportion of diastolic dysfunction was significant in men and women with OSA. Compared with non-OSA patients, nondipping systolic blood pressure in OSA was higher in men (14.3% vs 46.4%) and in women (41.4% vs 65.2%). OSA was independently associated with pulse wave velocity (β=1.050; P=.025) and nondipping systolic blood pressure (odds ratio, 3.03; 95% confidence interval, 1.08-8.55; P=.035) in the regression analysis. In conclusion, OSA is independently associated with arterial stiffness and nondipping blood pressure in patients with hypertension regardless of sex. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
12. Abnormalities of Anthropometric, Hemodynamic, and Autonomic Variables in Offspring of Hypertensive Parents.
- Author
-
Motta, Josiane M., Lemos, Tércio M., Consolim ‐ Colombo, Fernanda M., Moyses, Rosa M.A., Gusmão, Marcelo A.N., Egan, Brent M., Lopes, Heno F., Lemos, Tércio M, Consolim-Colombo, Fernanda M, and Gusmão, Marcelo A N
- Subjects
ANTHROPOMETRY ,AUTONOMIC nervous system ,BLOOD pressure ,CARBOHYDRATES ,FAMILY health ,HEMODYNAMICS ,HYPERTENSION ,ORAL drug administration ,PARENTS - Abstract
Young adult offspring of hypertensive parents (pHTN⊕) are a good model for assessing abnormalities of anthropometric, cardiometabolic, and autonomic variables prior to clinical hypertension. The objectives of this study were to determine whether these variables and autonomic responses to oral carbohydrates were altered in offspring of pHTN⊕. Two hundred consecutive patients, including 100 pHTN⊕, were evaluated, with 29 patients, including 14 pHTN⊕, given a 70-gram carbohydrate load. The pHTN⊕ group had higher blood pressure, pulse pressure, abdominal circumference (AC), weight, body mass index, and basal metabolic rate than offspring of normotensive parents (pHTN∅). At baseline, the low-frequency (LF, sympathetic) to high-frequency (HF, parasympathetic) ratio, assessed by spectral analysis of heart rate variability, was similar in both groups. After the carbohydrate load, the LF/HF ratio was greater in offspring of pHTN⊕. pHTN⊕ individuals have abnormalities of anthropometric and hemodynamic variables at baseline and autonomic responses to oral carbohydrates before developing hypertension. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
13. Visceral adiposity syndrome.
- Author
-
Lopes, Heno F., Corrêa-Giannella, Maria Lúcia, Consolim-Colombo, Fernanda M., and Egan, Brent M.
- Subjects
- *
OBESITY , *WAIST circumference , *BLOOD pressure , *GLUCOSE , *LIPID metabolism , *METABOLIC syndrome - Abstract
The association of anthropometric (waist circumference) and hemodynamic (blood pressure) changes with abnormalities in glucose and lipid metabolism has been motivation for a lot of discussions in the last 30 years. Nowadays, blood pressure, body mass index/abdominal circumference, glycemia, triglyceridemia, and HDL-cholesterol concentrations are considered in the definition of Metabolic syndrome, referred as Visceral adiposity syndrome (VAS) in the present review. However, more than 250 years ago an association between visceral and mediastinal obesity with hypertension, gout, and obstructive apnea had already been recognized. Expansion of visceral adipose tissue secondary to chronic over-consumption of calories stimulates the recruitment of macrophages, which assume an inflammatory phenotype and produce cytokines that directly interfere with insulin signaling, resulting in insulin resistance. In turn, insulin resistance (IR) manifests itself in various tissues, contributing to the overall phenotype of VAS. For example, in white adipose tissue, IR results in lipolysis, increased free fatty acids release and worsening of inflammation, since fatty acids can bind to Toll-like receptors. In the liver, IR results in increased hepatic glucose production, contributing to hyperglycemia; in the vascular endothelium and kidney, IR results in vasoconstriction, sodium retention and, consequently, arterial hypertension. Other players have been recognized in the development of VAS, such as genetic predisposition, epigenetic factors associated with exposure to an unfavourable intrauterine environment and the gut microbiota. More recently, experimental and clinical studies have shown the autonomic nervous system participates in modulating visceral adipose tissue. The sympathetic nervous system is related to adipose tissue function and differentiation through beta1, beta2, beta3, alpha1, and alpha2 adrenergic receptors. The relation is bidirectional: sympathetic denervation of adipose tissue blocks lipolysis to a variety of lipolytic stimuli and adipose tissue send inputs to the brain. An imbalance of sympathetic/parasympathetic and alpha2 adrenergic/beta3 receptor is related to visceral adipose tissue storage and insulin sensitivity. Thus, in addition to the well-known factors classically associated with VAS, abnormal autonomic activity also emerges as an important factor regulating white adipose tissue, which highlights complex role of adipose tissue in the VAS. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
14. Influence of acute hyperlipidemia to adipocytederived hormones in lean normotensive and subjects with metabolic syndrome.
- Author
-
Lopes, Heno F., Klein, Richard L., Garvey, W. Timothy, Goodfriend, Theodore, and Egan, Brent M.
- Subjects
- *
HYPERLIPIDEMIA , *METABOLIC syndrome , *FAT cells , *ADIPONECTIN , *LEPTIN , *BODY mass index , *TRIGLYCERIDES - Abstract
Background Adipocyte-derived factors and regulators likely contribute to the metabolic syndrome (MetS) in patients with central obesity. This study was undertaken to assess the contribution of leptin, adiponectin, and acylation stimulating protein (ASP-C3ades/ARG) to hemodynamic (blood pressure [BP]) and metabolic (insulin, glucose, lipids) features of MetS. Methods In this study, leptin, adiponectin, and C3ades/ARG were measured at baseline and in response to an infusion of Intralipid® and heparin in 12 lean healthy controls and 12 patients with MetS. Results Baseline plasma leptin (27.6 ± 6.2 vs. 10.9 ± 3.8 ng/mL, p < 0.01) and plasma C3ades/ARG (273 ± 79 vs 198 ± 57 mg/dL, p < 0.05) were higher in the MetS than control group, whereas baseline plasma adiponectin was higher in the control than MetS group (9.9 ± 1.9 vs. 5.4 ± 0.6 g/mL). Plasma leptin correlated with body mass index (BMI), systolic and diastolic BP (r = 0.53-0.77, p < 0.01). Conversely, adiponectin correlated inversely with insulin, glucose, waist circumference, and insulin sensitivity (r = 0.48-0.51, p ≤ 0.02). Plasma triglycerides increased similarly in MetS and control groups after 4-hours of Intralipid and heparin. C3ades/ARG increased only in lean volunteers. The decrease in triglycerides 1-hour postinfusion was lower in the MetS than control group (-116 ± 33 vs. -282 ± 81 mg/dL, p = 0.01) and correlated inversely with the change in C3ades/ARG. Conclusion These data suggest that leptin is more closely associated with hemodynamic (BP) aspects of MetS, whereas adiponectin and C3ades/ARG are more closely associated with metabolic components. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
15. The Impact of Obstructive Sleep Apnea on Metabolic and Inflammatory Markers in Consecutive Patients with Metabolic Syndrome.
- Author
-
Drager, Luciano F., Lopes, Heno F., Maki-Nunes, Cristiane, Trombetta, Ivani C., Toschi-Dias, Edgar, Alves, Maria Janieire N. N., Fraga, Raffael F., Jun, Jonathan C., Negrão, Carlos E., Krieger, Eduardo M., Polotsky, Vsevolod Y., and Lorenzi-Filho, Geraldo
- Subjects
- *
APNEA , *METABOLIC syndrome , *SLEEP disorders , *POLYSOMNOGRAPHY , *DISEASE prevalence , *BLOOD pressure measurement , *GLUCOSE , *TRIGLYCERIDES , *CHOLESTEROL - Abstract
Background: Obstructive Sleep Apnea (OSA) is tightly linked to some components of Metabolic Syndrome (MetS). However, most of the evidence evaluated individual components of the MetS or patients with a diagnosis of OSA that were referred for sleep studies due to sleep complaints. Therefore, it is not clear whether OSA exacerbates the metabolic abnormalities in a representative sample of patients with MetS. Methodology/Principal Findings: We studied 152 consecutive patients (age 48±9 years, body mass index 32.3±3.4 Kg/m2) newly diagnosed with MetS (Adult Treatment Panel III). All participants underwent standard polysomnography irrespective of sleep complaints, and laboratory measurements (glucose, lipid profile, uric acid and C-reactive protein). The prevalence of OSA (apnea-hypopnea index ⩾15 events per hour of sleep) was 60.5%. Patients with OSA exhibited significantly higher levels of blood pressure, glucose, triglycerides, cholesterol, LDL, cholesterol/HDL ratio, triglycerides/HDL ratio, uric acid and C-reactive protein than patients without OSA. OSA was independently associated with 2 MetS criteria: triglycerides: OR: 3.26 (1.47-7.21) and glucose: OR: 2.31 (1.12-4.80). OSA was also independently associated with increased cholesterol/HDL ratio: OR: 2.38 (1.08-5.24), uric acid: OR: 4.19 (1.70-10.35) and C-reactive protein: OR: 6.10 (2.64-14.11). Indices of sleep apnea severity, apnea-hypopnea index and minimum oxygen saturation, were independently associated with increased levels of triglycerides, glucose as well as cholesterol/HDL ratio, uric acid and C-reactive protein. Excessive daytime sleepiness had no effect on the metabolic and inflammatory parameters. Conclusions/Significance: Unrecognized OSA is common in consecutive patients with MetS. OSA may contribute to metabolic dysregulation and systemic inflammation in patients with MetS, regardless of symptoms of daytime sleepiness. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
16. Endothelial Function Is Preserved in Chagas' Heart Disease Patients Without Heart Failure.
- Author
-
Consolim-Colombo, Fernanda M., Lopes, Heno F., Rosetto, Eliana A., Rubira, Marcelo C., Barreto-Filho, José Auguston S., Baruzzi, Antonio Cláudio A., and Krieger, Eduardo M.
- Subjects
- *
CHAGAS' disease , *ENDOTHELIUM , *EPITHELIUM , *TISSUES , *BLOOD circulation , *HEART diseases , *CARDIOVASCULAR diseases , *BLOOD flow , *HEMODYNAMICS - Abstract
Endothelium may be damaged, especially at the coronary, microcirculation, in animal models of Chagas' disease by several mechanisms. Endothelial dysfunction has been reported in chronic Chagas' heart disease patients with heart failure. Nevertheless, peripheral endothelial function has never been studied in patients with Chagas' heart disease without heart failure and other conditions that could per se alter the endothelial function. Endothelial function was evaluated in 9 patients with Chagas' heart disease (44.8 ± 1.5 years, 5 females, left ventricular ejection fraction ⩾ 60%) and 10 healthy matched controls (38.6 ± 5.5 years, 5 females). Extreme caution was exercised to select patients with no other conditions that could per se alter the endothelial function. Forearm blood flow was measured at baseline and during intrabrachial artery infusion of crescent doses of acetylcholine (0.75, 5, and 15 μg/100 ml. tissue/min) and nitroprusside (1.2, and 4 μg/100 mL tissue/min), an endothelium-dependent and an endothelium-independent vasoactive drug, respectively. At baseline, blood pressure and heart rate (continuously recorded with Finapress) and the forearm blood flow were similar in both groups. Acetylcholine (ACh) and sodium nitroprusside (SNP) caused significant and similar dose-dependent increases in forearm blood flow of all subjects: maximum ACh response of 24.8 versus 23.7, and maximum SNP response 24.4 versus 23.7 mL/100 mL tissue/min, respectively, for control and chagasic Groups. No significant systemic hemodynamic changes were observed during the intra-arterial infusion of the drugs. The authors conclude that the peripheral endothelial function is preserved in Chagas' heart disease patients without heart failure. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
17. Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster.
- Author
-
Stojiljkovic, Milos P, Lopes, Heno F, Zhang, Da, Morrow, Jason D, Goodfriend, Theodore L, and Egan, Brent M
- Published
- 2002
- Full Text
- View/download PDF
18. Moderate Sodium Restriction Enhances the Pressor Response to Hyperlipidemia in Obese, Hypertensive Patients.
- Author
-
Lopes, Heno F., Stojiljkovic, Milos P., Zhang, Da, Goodfriend, Theodore L., and Egan, Brent M.
- Published
- 2002
- Full Text
- View/download PDF
19. The pressor response to acute hyperlipidemia is enhanced in lean normotensive offspring of hypertensive parents*.
- Author
-
Lopes, Heno F., Stojiljkovic, Milos P., Zhang, Da, Goodfriend, Theodore L., and Egan, Brent M.
- Published
- 2001
- Full Text
- View/download PDF
20. Hemodynamic effects of lipids in humans.
- Author
-
Stojilkovic, Milos P., Zhang, Da, Lopes, Heno F., Lee, Christine G., Goodfriend, Theodore L., and Egan, Brent M.
- Subjects
FATTY acids ,LIPIDS ,HEPARIN ,HEMODYNAMICS ,PHYSIOLOGY - Abstract
Presents a study which addressed the hemodynamic effects of raising nonesterified fatty acids (NEFA) with Intralipid and heparin in humans. Methods used; Changes in plasma NEFA concentrations during the infusions of saline and heparin; Discussion.
- Published
- 2001
- Full Text
- View/download PDF
21. Hypertensive heart disease: Benefit of carvedilol in hemodynamic, left ventricular remodeling, and survival.
- Author
-
Dominguez, Renata F, da Costa-Hong, Valeria A, Ferretti, Luan, Fernandes, Fabio, Bortolotto, Luiz A, Consolim-Colombo, Fernanda M, Egan, Brent M, and Lopes, Heno F
- Published
- 2019
- Full Text
- View/download PDF
22. 136 DETERMINANTS OF FUNCTIONAL AND STRUCTURAL PROPERTIES OF LARGE ARTERIES AND THE CORRELATIONS WITH END-ORGAN DAMAGE IN STAGE III HYPERTENSIVE PATIENTS.
- Author
-
Sousa, Marcio Gonçalves, Hong, Valéria C, Drager, Luciano F, Lopes, Heno F, Harum, Elias, Giorgi, Dante MA, and Bortolotto, Luiz A
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.